Revvity Inc (RVTY)
116.22
+0.63
(+0.55%)
USD |
NYSE |
Jan 07, 15:48
Revvity Research and Development Expense (Annual): 216.58M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bionano Genomics Inc | 54.03M |
| Bruker Corp | 294.80M |
| Azenta Inc | 33.52M |
| Harvard Bioscience Inc | 11.76M |
| Akoya Biosciences Inc | 21.89M |